Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

NRSNNRSN
Showing 8 of 11 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in NEUROSENSE THERAPEUTICS LTD

GEODE CAPITAL MANAGEMENT, LLC holds 15,870 shares of NRSN (NEUROSENSE THERAPEUTICS LTD), worth $11,426 as of 2026-Q2.

Current Value

$11,426

Current Shares

15,870

Total Value Change

-$3,767

Total Shares Change

+3,907

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
15,870
0.0%
$11,4260.0%$0.72
0
2026-Q1
Unchanged
15,870
0.0%
$11,9810.0%$0.85
0
2025-Q4
Unchanged
15,870
0.0%
$12,2040.0%$0.71
0
2025-Q3
Unchanged
15,870
0.0%
$19,8370.0%$1.25
0
2025-Q2
Unchanged
15,870
0.0%
$29,9940.0%$1.90
0
2025-Q1
Unchanged
15,870
0.0%
$14,6030.0%$1.00
0
2024-Q4
Increased
15,870
+32.7%
$19,0440.0%$1.24
16
2024-Q3
Unchanged
11,963
0.0%
$15,1930.0%$1.28
0

Other major holders of NRSN: CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, Hudson Bay Capital Management LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used